Newsletter Subscribe
Enter your email address below and subscribe to our newsletter
Treatment
Share your love
FDA accepts resubmitted ONS-5010 BLA from Outlook Therapeutics | Ophthalmology Times
(Image Credit: AdobeStock) The FDA has accepted for review a biologics license application (BLA) from Outlook Therapeutics for ONS-5010 (bevacizumab-vikg) for the treatment of wet age-related macular degeneration (wet AMD). ONS-5010 is a recombinant humanized monoclonal antibody (mAb) that selectively…
Apellis announces 5-year GALE study data in GA | Ophthalmology Times
Image credit: ©Proxima Studio/AdobeStock) Apellis Pharmaceuticals recently announced post hoc analysis data from the GALE extension study. The new data are the result of 5 years of continuous treatment with pegcetacoplan injection (Syfovre) in patients with geographic atrophy (GA) secondary…
AAO 2025: Effect of cryopreserved amniotic membrane after corneal cross-linking in patients with keratoconus | Ophthalmology Times
Reena Gupta, MD, a cornea, cataract, and refractive surgeon at Omni Eye Services, discusses the findings and implications of a retrospective study regarding the use of cryopreserved amniotic membrane for patients undergoing corneal cross-linking (CXL), comparing it to the traditional…
Understanding Tear Composition and Function in Dry Eye Disease | Ophthalmology Times
The Viewpoints series “Reimagining Dry Eye Management: Targeting Tear Function for Sustained Relief” convenes leading experts in ophthalmology and optometry to discuss evolving perspectives on dry eye disease (DED). Under the moderation of Kendall Donaldson, MD, MS, the panel—comprising Cecelia…
Identification and Diagnosis of Dry Eye Disease | Ophthalmology Times
The Viewpoints series “Reimagining Dry Eye Management: Targeting Tear Function for Sustained Relief” convenes leading experts in ophthalmology and optometry to discuss evolving perspectives on dry eye disease (DED). Under the moderation of Kendall Donaldson, MD, MS, the panel—comprising Cecelia…
Q&A: James Chelnis discusses AAO 2025 presentation on aesthetic facial surgery | Ophthalmology Times
Image credit: AdobeStock/Viacheslav Yakobchuk James Chelnis, MD, FACS, is an ophthalmic plastic and reconstructive surgeon at Manhattan Face & Eye. At the 2025 American Academy of Ophthalmology meeting held in Orlando, Florida, he gave a presentation titled, “Introduction to Aesthetic…
LASIK and beyond: Navigating the changing landscape of refractive surgery | Ophthalmology Times
Ophthalmologists share how emerging LASIK techniques and technologies are improving outcomes and shaping the future of refractive surgery. (Image credit: AdobeStock/rohane) Refractive surgery continues to transform, with innovations in LASIK and other vision-correction procedures improving precision and patient outcomes. The…
A Systematic Approach to Diagnosing and Managing Demodex Blepharitis in Everyday Practice | Ophthalmology Times
The program begins with a discussion on the everyday challenges eye care professionals face in recognizing subtle signs of eyelid disease. The speaker explains how a structured clinical workflow—combining careful slit-lamp examination, patient history, and microscopic confirmation—can help practitioners avoid…
Pediatric and strabismus care: Evolving tools, emerging therapies | Ophthalmology Times
Advances in imaging, diagnostics, and surgical techniques are transforming the detection and treatment of pediatric and strabismus disorders. (Image credit: AdobeStock/FOTO_STOCKER) Pediatric ophthalmology continues to evolve, with advances in diagnostic imaging, surgical techniques, and emerging therapies reshaping the management of…
Transformative advances in vision research: It’s the science | Ophthalmology Times
(Image Credit: AdobeStock/kkolosov) As part of Ophthalmology Times’ 50th anniversary celebration, leaders in the field are reflecting on the transformative role of science and research in advancing eye care. Deborah A. Ferrington, PhD—chief scientific officer and the Stephen J. Ryan–Arnold…